Categories Uncategorized

Earth Science Tech Inc. (ETST) Seeks to Implement a Unified Strategy to Unlock True Market Value and Support Shareholders

  • Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate governance
  • The company will hold a virtual annual meeting on August 31, 2026, during which shareholders will vote on key initiatives that will position ETST for an uplisting to a higher-tier exchange, eliminate the structural barriers that hinder the infusion of institutional capital, and prevent stock dilution
  • These initiatives are informed by extensive dialogue between shareholders and management leading to a consensus that the company’s current market valuation simply does not accurately reflect its financial success or future potential

The recent annual financial results posted by Earth Science Tech (OTC: ETST) reflect significant success and growth, which the diversified holding company attributes to an overarching focus on optimizing internal operations. The company, for instance, logged consecutive year-over-year increases in revenue and gross profit in the two years to March 31, 2026 (https://ibn.fm/GQzTa), and has maintained positive cash flow, establishing a strong operational and financial foundation.

ETST’s management is nonetheless building on this foundation to expand the company’s focus toward the capital market and is keen on securing shareholder buy-in to implement a unified strategy aimed at resolving structural hurdles and elevating corporate governance. Specifically, the company is looking to position itself for an uplisting and is intent on eliminating the structural barriers that hinder the infusion of institutional capital.

The execution of this unified strategy hinges on four key initiatives that emerged from extensive dialogue with retail shareholders and institutional investors. (These initiatives will be on the voting agenda at an upcoming annual meeting.) The first initiative seeks to eliminate the existing dual-class voting structure, which dissuades institutional investors from buying into the company. Shareholders can authorize, by way of a vote, the Board’s independent Special Committee to negotiate the cash-only purchase and retirement of the CEO’s Series B Preferred Stock, which holds super-voting power.

Shareholders will also vote on an advisory recommendation to pursue a reverse stock split that will be implemented only if deemed necessary by the Board. The second initiative is aimed at enabling Earth Science Tech to achieve the minimum bid price required to uplist to a higher-tier exchange, such as Nasdaq, NYSE American, or OTCQX. Shareholders can also vote to stop the issuance of stock options, equity bonuses, or other stock-based incentives as executive compensation in favor of cash-centric remuneration. This third initiative is geared toward protecting equity by preventing dilution. The last initiative relates to standard governance matters.

“Our primary directive is to maximize value for our shareholders,” commented Giorgio R. Saumat, CEO and Chairman of the Board. “Over the last few years, we put our heads down to drive operational excellence. That hard work has resulted in consistent positive cash flow and allowed us to actively buy back our own stock, fortifying our balance sheet. However, having listened closely to the feedback from our investors and institutional partners, we agree that our current market valuation simply does not accurately reflect our financial success or future potential.”

Accordingly, the company’s proxy statement, filed with the SEC (https://ibn.fm/lf6ds), represents the company’s efforts to address shareholders’ concerns, protect their equity, and prepare for institutional growth. ETST invites all shareholders to participate in the vote, which is scheduled to be held during its virtual annual meeting on August 31, 2026. “We invite all shareholders to participate in this vote and join us in unlocking our true market value,” concluded Mr. Saumat.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Little-Known Immune Cells Bolster Anticancer Fight, Study Finds

Researchers from the University of Manchester in the UK have found that a small group…

7 hours ago

Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with…

8 hours ago

Global Drugmakers Earmark Billions to Ramp Up Their US Footprint

Dozens of global drugmakers are ramping up their investments in the United States in a bid to…

1 day ago

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around…

1 day ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Researchers recognize…

2 days ago

Deadly Infection Surges, Prompts Health Officials to Caution Beachgoers

Beachgoers on the Gulf Coast in the U.S. have been urged to exercise caution in order to limit…

3 days ago